Status:
ACTIVE_NOT_RECRUITING
Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis
Lead Sponsor:
University of Crete
Conditions:
Hashimoto Disease
Psoriasis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Hashimoto's disease (HT) and psoriasis (PsO) have a significant impact on patient's quality of everyday life, and early diagnosis is critical for the symptoms management and prognosis. There is eviden...
Detailed Description
Patients with Hashimoto's thyroiditis (HT), patients with psoriasis (PsO), and healthy individuals aged 18-60 will be recruited and assessed according to inclusion/exclusion criteria. Eligible partici...
Eligibility Criteria
Inclusion
- Hashimoto's Thyroiditis:
- Clinical findings
- Presence of thyroid autoantibodies (anti-TPO) in laboratory tests
- Gray-scale Ultrasound findings.
- Psoriasis:
- Presence of psoriatic lesions
- Psoriasis Area and Severity Index score (PASI).
- Healthy group:
- Non-obese (BMI\<30)
- non-athletes
- non-pregnant or lactating women
- not been diagnosed with a chronic or acute disease
- not receiving antidepressants, drugs and supplements
- normal Thyroid Stimulating Hormone (TSH) levels or high TSH and absence of other clinical findings of thyroid malfunction.
- Exclusion Criteria:
- malignant or congenital goiter
- thyroidectomy
Exclusion
Key Trial Info
Start Date :
February 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04693936
Start Date
February 2 2021
End Date
December 1 2024
Last Update
June 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Metabolomic Medicine, Private Health Clinics
Athens, Greece